Treace Medical Concepts, Inc. $TMCI
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Ponte Vedra, FL
- Fiscal year end
- December 31
- Shares outstanding
- 65,034,552 [10-Q 2026-08-07]
What the company doesAI summary of filing
Treace Medical Concepts is a revenue-generating medical technology company that develops and sells surgical systems for correcting bunions and related midfoot deformities. The company sells its products primarily through a direct employee sales force and independent sales agencies to hospitals, ambulatory surgery centers, and surgeons in the United States. Its core product, the Lapiplasty 3D Bunion Correction System, is a combination of reusable surgical instruments and single-use sterile implants designed to correct bunion deformities in three dimensions. The company also offers complementary products including minimally invasive bunion correction systems, midfoot correction systems, great toe fusion implants, and patient-specific instrumentation, and generates revenue from sales of these products to healthcare facilities and surgeons. [10-K 2026-02-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $92.57M | −$33.83M | $2.54M | $12.61M | [10-Q 2026-08-07] |
| FY ended Dec 2025 | $212.69M | −$59.00M | −$15.97M | $10.71M | [10-K 2026-02-27] |
| FY ended Dec 2024 | $209.36M | −$55.74M | −$37.17M | $11.35M | [10-K 2026-02-27] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-31 | 62,297,078 | [10-Q 2024-11-05] |
| 2025-02-19 | 62,618,725 | [10-K 2025-02-27] |
| 2025-04-30 | 62,904,952 | [10-Q 2025-05-08] |
| 2025-07-31 | 63,173,126 | [10-Q 2025-08-07] |
| 2025-10-31 | 63,718,073 | [10-Q 2025-11-06] |
| 2026-02-20 | 64,590,503 | [10-K 2026-02-27] |
| 2026-04-30 | 64,872,976 | [10-Q 2026-05-08] |
| 2026-07-31 | 65,034,552 | [10-Q 2026-08-07] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-30 | Elder Scot Michael | other | 25,457 | — | [4 2026-10-02] |
| 2026-08-24 | Treace John T. | buy | 11,000 | $4.34 | [4 2026-08-24] |
| 2026-08-21 | Treace John T. | buy | 5,000 | $4.35 | [4 2026-08-24] |
| 2026-08-20 | Treace John T. | buy | 39,944 | $4.44 | [4 2026-08-24] |
| 2026-08-09 | Scanlan Sean F. | other | 9,814 | — | [4 2026-08-12] |
| 2026-08-09 | Hair Mark | other | 37,102 | — | [4 2026-08-12] |
| 2026-08-09 | Elder Scot Michael | other | 16,253 | — | [4 2026-08-12] |
| 2026-06-11 | Treace John T. | buy | 22,887 | $4.04 | [4 2026-06-11] |
| 2026-06-10 | Treace John T. | buy | 29,430 | $4.02 | [4 2026-06-11] |
| 2026-06-01 | Treace John T. | buy | 50,000 | $3.56 | [4 2026-06-01] |
| 2026-05-28 | Treace John T. | buy | 61,202 | $3.02 | [4 2026-05-28] |
| 2026-05-27 | Treace John T. | buy | 49,810 | $2.87 | [4 2026-05-28] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-07 | 10-Q | Quarterly report |
| 2026-08-07 | 8-K | Results of operations |
| 2026-07-30 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-20 | 8-K | Shareholder vote results |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-14 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-05-08 | 10-Q | Quarterly report |
| 2026-05-08 | 8-K | Results of operations |
| 2026-04-09 | 8-K | Results of operations; Director or officer change; Regulation FD disclosure |
| 2026-04-06 | DEF 14A | Proxy statement |
Alerts for $TMCI
Email me when Treace Medical Concepts, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.